Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Analysis of p53 mutations in endometrial tumours from tamoxifen-treated women

Karen Brown, Helen Pearson, Peter B. Farmer, Patrick Neven, Paul L. Carmichael

Cancer Res (2004) 64 (7_Supplement): 1123.

Published: 01 April 2004

View article

Journal Articles

Microarray analysis of gene expression in a model endometrial carcinoma cell line treated with selective estrogen receptor modulators (SERMs).

Suzanne C. Drury, Andrea Coles, Paul L. Carmichael

Cancer Res (2004) 64 (7_Supplement): 747.

Published: 01 April 2004

View article

Journal Articles

Genotoxicity of Human Mammary Lipid

Francis L. Martin, Paul L. Carmichael, Christopher Crofton-Sleigh, Stanley Venitt, David H. Phillips, Philip L. Grover

Cancer Res (1996) 56 (23): 5342–5346.

Published: 01 December 1996

View article

Journal Articles

Lack of Genotoxicity of Tamoxifen in Human Endometrium

Paul L. Carmichael, Austin H. N. Ugwumadu, Patrick Neven, Alan J. Hewer, Grace K. Poon, David H. Phillips

Cancer Res (1996) 56 (7): 1475–1479.

Published: 01 April 1996

View article

Journal Articles

Identification of the Major Tamoxifen-Deoxyguanosine Adduct Formed in the Liver DNA of Rats Treated with Tamoxifen

Martin R. Osborne, Alan Hewer, Ian R. Hardcastle, Paul L. Carmichael, David H. Phillips

Cancer Res (1996) 56 (1): 66–71.

Published: 01 January 1996

View article

Journal Articles

α-Hydroxytamoxifen, a Metabolite of Tamoxifen with Exceptionally High DNA-binding Activity in Rat Hepatocytes

David H. Phillips, Paul L. Carmichael, Alan Hewer, Kathleen J. Cole, Grace K. Poon

Cancer Res (1994) 54 (21): 5518–5522.

Published: 01 November 1994

View article

Journal Articles

Evidence for the Involvement of a Bis-Diol-Epoxide in the Metabolic Activation of Dibenz[a,h]anthracene to DNA-binding Species in Mouse Skin

Paul L. Carmichael, Karl L. Platt, Meadhbh Ní Shé, Sophie Lecoq, Franz Oesch, David H. Phillips, Philip L. Grover

Cancer Res (1993) 53 (5): 944–948.

Published: 01 March 1993

View article

NARROW

Analysis of p53 mutations in endometrial tumours from tamoxifen-treated women

Microarray analysis of gene expression in a model endometrial carcinoma cell line treated with selective estrogen receptor modulators (SERMs).

Genotoxicity of Human Mammary Lipid

Lack of Genotoxicity of Tamoxifen in Human Endometrium

Identification of the Major Tamoxifen-Deoxyguanosine Adduct Formed in the Liver DNA of Rats Treated with Tamoxifen

α-Hydroxytamoxifen, a Metabolite of Tamoxifen with Exceptionally High DNA-binding Activity in Rat Hepatocytes

Evidence for the Involvement of a Bis-Diol-Epoxide in the Metabolic Activation of Dibenz[a,h]anthracene to DNA-binding Species in Mouse Skin

Email alerts

AACR Journals

Analysis of p53 mutations in endometrial tumours from tamoxifen-treated women

Microarray analysis of gene expression in a model endometrial carcinoma cell line treated with selective estrogen receptor modulators (SERMs).

Genotoxicity of Human Mammary Lipid

Lack of Genotoxicity of Tamoxifen in Human Endometrium

Identification of the Major Tamoxifen-Deoxyguanosine Adduct Formed in the Liver DNA of Rats Treated with Tamoxifen

α-Hydroxytamoxifen, a Metabolite of Tamoxifen with Exceptionally High DNA-binding Activity in Rat Hepatocytes

Evidence for the Involvement of a Bis-Diol-Epoxide in the Metabolic Activation of Dibenz[a,h]anthracene to DNA-binding Species in Mouse Skin

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only